BrainCo bets wearables, not implants, to scale brain-computer interfaces
Hangzhou’s BrainCo is pursuing non-invasive wearable brain-computer interfaces to broaden use beyond medical implants, leveraging FDA‑approved bionic hands and a sleep-wellness device, and backed by roughly 2 billion yuan in funding. The company envisions a staged roadmap—from aiding amputees and neurological conditions to consumer electronics—and plans to license its BCI platform to others. China’s Five-Year Plan backs BCI development and regulators have approved minimally invasive devices, underscoring a US‑China tech race. Debates persist over whether non-invasive approaches can deliver mass-market adoption and what data-privacy implications will arise, with market size still uncertain.